Alk-Abello ASCHIX:ALKBC 92 Forward PE Ratio is 33.69 as of Jul. 13, 2026. GuruFocus rates CHIX:ALKBC with a GF Score™ of 92/100 and a GF Value™ of kr208.11 (Modestly Overvalued). Among 354 Biotechnology companies, Alk-Abello AS ranks worse than 64.97% on this metric.
Alk-Abello AS's Forward PE Ratio for today is 33.69.
Alk-Abello AS (CHIX:ALKBc) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Alk-Abello AS Forward PE Ratio Related Terms
Alk-Abello AS Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Alk-Abello AS's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS Forward PE Ratio Chart
Alk-Abello AS Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
29.87
35.38
Alk-Abello AS Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
29.87
25.66
34.21
31.93
35.38
32.20
CHIX:ALKBC vs VRTX, REGN, ALNY: Forward PE Ratio Comparison
For the Biotechnology subindustry, Alk-Abello AS's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS Forward PE Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Alk-Abello AS (CHIX:ALKBC) has a Forward PE Ratio of 33.69 as of Jul. 13, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Alk-Abello AS and its competitors. According to the industry distribution chart, Alk-Abello AS ranks #230 out of 354 companies in the Biotechnology industry, placing it in the top 65%.
Is Alk-Abello AS's Forward PE Ratio too high?
Alk-Abello AS's current Forward PE Ratio is 33.69. The Biotechnology industry median Forward PE Ratio is 22.13. Alk-Abello AS's value of 33.69 is 52.3% above this industry median. Based on the distribution chart, Alk-Abello AS ranks #230 out of 354 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alk-Abello AS has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Forward PE Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #230 out of 354 companies for Forward PE Ratio. This places Alk-Abello AS in the lower half of its industry. The industry median Forward PE Ratio is 22.13. Alk-Abello AS's value of 33.69 is 52.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Biotechnology company?
The median Forward PE Ratio among Biotechnology companies is 22.13, based on 354 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alk-Abello AS's current Forward PE Ratio of 33.69 is 52.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Alk-Abello AS and its competitors. For the Biotechnology industry, the median Forward PE Ratio is 22.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alk-Abello AS's current Forward PE Ratio is 33.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr208.11, compared to a current price of kr256.30 — trading 23.2% above its estimated fair value. The current Forward PE Ratio is 33.69 and 52.3% above the Biotechnology industry median of 22.13. Alk-Abello AS's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Forward PE Ratio is 33.69 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued.
The current stock price of kr256.30 is trading 23.2% above its estimated GF Value™ of kr208.11.
GuruFocus considers Alk-Abello AS to be Modestly Overvalued.
Key valuation signals for CHIX:ALKBC:
Forward PE Ratio: 33.69
GF Value™: kr208.11 vs. price of kr256.30 (23.2% above fair value)
Industry Position: 52.3% above the Biotechnology median (#230 of 354)
No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
92GF Score
Get the complete analysis for CHIX:ALKBC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ALKBC has been successfully added to your 